News

QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

  • 2026-10-27 06:15:00

Qualtech's webinar on September 17, 2026 reviewed key regulatory developments for medical devices in Japan and South Korea. The Japan session covered how existing biocompatibility reports can support PMDA submissions, including JIS T 0993-1:2020 requirements, material documentation, GLP compliance and the acceptance of overseas test data. The South Korea session outlined the Digital Medical Products Act framework, covering device status determination, classification, regulatory pathways, K-GMP and post-market obligations.

More
Qualtech Webinar: ASEAN Regulatory Briefing – Thailand & Malaysia – October 2026

Qualtech Webinar: ASEAN Regulatory Briefing – Thailand & Malaysia – October 2026

  • 2026-10-09 01:44:32

Qualtech invites you to our free webinar on Thursday, October 29, 2026, with the topic "ASEAN Regulatory Briefing: Thailand & Malaysia - Critical Updates Impacting Medical Device Market Access".
Our local regulatory experts from Thailand and Malaysia will share practical insights into the latest regulatory changes, updated requirements, and key considerations affecting medical device registration and regulatory compliance. This session is highly recommended for all medical device manufacturers currently active in, or planning to enter, the Thailand and Malaysian market.

More
QUALTECH WEBINAR: JAPAN & SOUTH KOREA – KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September 2026

QUALTECH WEBINAR: JAPAN & SOUTH KOREA – KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September 2026

  • 2026-08-25 04:02:15

Planning to enter or expand your medical device business in Japan or South Korea? Join Qualtech's free webinar on September 17, 2026, for a focused discussion on key regulatory developments shaping medical device market access in these two important Asian markets.
The session will cover practical considerations for leveraging existing biocompatibility reports for PMDA requirements and navigating South Korea’s evolving framework for digital healthcare products and digital medical devices.

More
QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

  • 2026-04-23 07:36:58

The webinar hosted by Qualtech in March takes a closer look at how medical device studies are conducted in the United States. Covering US FDA classification, IDE and IRB pathways, and study design, it connects regulatory frameworks with their practical application in study execution. This recap highlights key considerations shaping how studies are structured and managed in the US context.

More
Qualtech Webinar: Navigating Medical Device Studies in the US - Regulatory Strategy, Study Design, and Subject Management - March 2026

Qualtech Webinar: Navigating Medical Device Studies in the US - Regulatory Strategy, Study Design, and Subject Management - March 2026

  • 2026-03-04 08:36:52

Join Qualtech's free webinar, "Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management" on March 26, 2026. This complimentary session is designed to provide clear and practical insights into US regulatory expectations, study design considerations, and effective subject management strategies.

Take advantage of this opportunity to strengthen your understanding of US medical device study requirements

More
QT ACTIVITY: NAVIGATING INDIA'S MEDICAL DEVICE REGULATORY LANDSCAPE WEBINAR RECAP - MAY/JUNE 2025

QT ACTIVITY: NAVIGATING INDIA'S MEDICAL DEVICE REGULATORY LANDSCAPE WEBINAR RECAP - MAY/JUNE 2025

  • 2025-06-03 07:01:37

On April 24, 2025, Qualtech hosted a webinar focused on navigating the regulatory landscape for medical devices in India. The session was presented by Mr. Anil Chaudhari, Founder and CEO of Operon Strategist, and Ms. Lakshmi Ranjith, Manager of Regulatory Affairs of Operon Strategist. Together, they provided a detailed overview of India’s regulatory system, including the roles of CDSCO and state licensing authorities, the classification of medical devices by risk level, the registration process, and best practices for compliance. The following summary highlights the key insights and essential regulatory requirements, offering valuable guidance for medical device companies seeking to enter or expand in the India market.

More